Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy

• Reid Shaw,
• James J. Yoon,
• Hannah Johnston,
• Marta B. Davidson,
• Alexa J. Siddon,
• Rory M. Shallis,
• Evan C. Chen,
• Madelyn Burkart,
• Timothy S. Oh,
• Sunil G. Iyer,
• Ellen Madarang,
• Chandrasekar Muthiah,
• Joshua Kassner,
• Raajit K. Rampal,
• Guru Subramanian Guru Murthy,
• Terrence Bradley,
• Yasmin Abaza,
• Jacqueline S. Garcia,
• Vikas Gupta,
• Kristen M. Pettit,
• Olatoyosi Odenike,
• Anand A. Patel

Affiliations

Reid Shaw

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL

James J. Yoon

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Hannah Johnston

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL

Marta B. Davidson

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Alexa J. Siddon

Departments of Laboratory Medicine and Pathology, Yale School of Medicine, New Haven, CT

Rory M. Shallis

Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT

Evan C. Chen

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Madelyn Burkart

Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC

Timothy S. Oh

Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL

Sunil G. Iyer

Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY

Ellen Madarang

Department of Pharmacy, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Chandrasekar Muthiah

Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI

Joshua Kassner

Division of Hematology and Medical Oncology, Weill Department of Medicine, Cornell University, Ithaca, NY

Raajit K. Rampal

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Guru Subramanian Guru Murthy

Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI

Terrence Bradley

Department of Pharmacy, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Yasmin Abaza

Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL

Jacqueline S. Garcia

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Vikas Gupta

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Kristen M. Pettit

Division of Hematology and Medical Oncology, Department of Internal Medicine, University of Michigan Medical School, Michigan Medicine, Ann Arbor, MI

Olatoyosi Odenike

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL

Anand A. Patel

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL; Correspondence: Anand A. Patel, Section of Hematology/Oncology, University of Chicago, 5841 S Maryland Ave, MC 2115, Chicago, IL 60637;